Yulong Wei1, Jordan R Silke1, Parisa Aris1, Xuhua Xia1,2. 1. Department of Biology, University of Ottawa, Ottawa, Ontario, Canada. 2. Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Ontario, Canada.
Abstract
Coronaviruses such as SARS-CoV-2 regularly infect host tissues that express antiviral proteins (AVPs) in abundance. Understanding how they evolve to adapt or evade host immune responses is important in the effort to control the spread of infection. Two AVPs that may shape viral genomes are the zinc finger antiviral protein (ZAP) and the apolipoprotein B mRNA editing enzyme-catalytic polypeptide-like 3 (APOBEC3). The former binds to CpG dinucleotides to facilitate the degradation of viral transcripts while the latter frequently deaminates C into U residues which could generate notable viral sequence variations. We tested the hypothesis that both APOBEC3 and ZAP impose selective pressures that shape the genome of an infecting coronavirus. Our investigation considered a comprehensive number of publicly available genomes for seven coronaviruses (SARS-CoV-2, SARS-CoV, and MERS infecting Homo sapiens, Bovine CoV infecting Bos taurus, MHV infecting Mus musculus, HEV infecting Sus scrofa, and CRCoV infecting Canis lupus familiaris). We show that coronaviruses that regularly infect tissues with abundant AVPs have CpG-deficient and U-rich genomes; whereas those that do not infect tissues with abundant AVPs do not share these sequence hallmarks. Among the coronaviruses surveyed herein, CpG is most deficient in SARS-CoV-2 and a temporal analysis showed a marked increase in C to U mutations over four months of SARS-CoV-2 genome evolution. Furthermore, the preferred motifs in which these C to U mutations occur are the same as those subjected to APOBEC3 editing in HIV-1. These results suggest that both ZAP and APOBEC3 shape the SARS-CoV-2 genome: ZAP imposes a strong CpG avoidance, and APOBEC3 constantly edits C to U. Evolutionary pressures exerted by host immune systems onto viral genomes may motivate novel strategies for SARS-CoV-2 vaccine development.
panclass="Species">Coronaviruses such as class="Chemical">pan class="Species">SARS-CoV-2 regularly infect host tissues that express antiviral proteins (AVPs) in abundance. Understanding how they evolve to adapt or evade host immune responses is important in the effort to control the spread of infection. Two AVPs that may shape viral genomes are the zinc finger antiviral protein (ZAP) and the apolipoprotein B mRNA editing enzyme-catalytic polypeptide-like 3 (APOBEC3). The former binds to CpG dinucleotides to facilitate the degradation of viral transcripts while the latter frequently deaminates C into U residues which could generate notable viral sequence variations. We tested the hypothesis that both APOBEC3 and ZAP impose selective pressures that shape the genome of an infecting coronavirus. Our investigation considered a comprehensive number of publicly available genomes for seven coronaviruses (SARS-CoV-2, SARS-CoV, and MERS infecting Homo sapiens, BovineCoV infecting Bos taurus, MHV infecting Mus musculus, HEV infecting Sus scrofa, and CRCoV infecting Canis lupus familiaris). We show that coronaviruses that regularly infect tissues with abundant AVPs have CpG-deficient and U-rich genomes; whereas those that do not infect tissues with abundant AVPs do not share these sequence hallmarks. Among the coronaviruses surveyed herein, CpG is most deficient in SARS-CoV-2 and a temporal analysis showed a marked increase in C to U mutations over four months of SARS-CoV-2 genome evolution. Furthermore, the preferred motifs in which these C to U mutations occur are the same as those subjected to APOBEC3 editing in HIV-1. These results suggest that both ZAP and APOBEC3 shape the SARS-CoV-2 genome: ZAP imposes a strong CpG avoidance, and APOBEC3 constantly edits C to U. Evolutionary pressures exerted by host immune systems onto viral genomes may motivate novel strategies for SARS-CoV-2 vaccine development.
Authors: Nina Le Bert; Anthony T Tan; Kamini Kunasegaran; Christine Y L Tham; Morteza Hafezi; Adeline Chia; Melissa Hui Yen Chng; Meiyin Lin; Nicole Tan; Martin Linster; Wan Ni Chia; Mark I-Cheng Chen; Lin-Fa Wang; Eng Eong Ooi; Shirin Kalimuddin; Paul Anantharajah Tambyah; Jenny Guek-Hong Low; Yee-Joo Tan; Antonio Bertoletti Journal: Nature Date: 2020-07-15 Impact factor: 49.962
Authors: Jennifer L Meagher; Matthew Takata; Daniel Gonçalves-Carneiro; Sarah C Keane; Antoine Rebendenne; Heley Ong; Victoria K Orr; Margaret R MacDonald; Jeanne A Stuckey; Paul D Bieniasz; Janet L Smith Journal: Proc Natl Acad Sci U S A Date: 2019-11-12 Impact factor: 11.205
Authors: Md Shamimuzzaman; Justin J Le Tourneau; Deepak R Unni; Colin M Diesh; Deborah A Triant; Amy T Walsh; Aditi Tayal; Gavin C Conant; Darren E Hagen; Christine G Elsik Journal: Nucleic Acids Res Date: 2020-01-08 Impact factor: 16.971
Authors: Will Fischer; Elena E Giorgi; Srirupa Chakraborty; Kien Nguyen; Tanmoy Bhattacharya; James Theiler; Pablo A Goloboff; Hyejin Yoon; Werner Abfalterer; Brian T Foley; Houriiyah Tegally; James Emmanuel San; Tulio de Oliveira; Sandrasegaram Gnanakaran; Bette Korber Journal: Cell Host Microbe Date: 2021-06-03 Impact factor: 31.316
Authors: Andrea Di Gioacchino; Petr Šulc; Anastassia V Komarova; Benjamin D Greenbaum; Rémi Monasson; Simona Cocco Journal: Mol Biol Evol Date: 2021-05-19 Impact factor: 16.240
Authors: Tobias Mourier; Mukhtar Sadykov; Michael J Carr; Gabriel Gonzalez; William W Hall; Arnab Pain Journal: Biochem Biophys Res Commun Date: 2020-11-05 Impact factor: 3.575
Authors: Marina Muñoz; Luz Helena Patiño; Nathalia Ballesteros; Sergio Castañeda; Nicolás Luna; Lourdes Delgado; Carlos Hernandez-Pereira; Maryia V Shaban; Shirly Alexandra Muñoz; Alberto Paniz-Mondolfi; Juan David Ramírez Journal: One Health Date: 2021-12-16
Authors: Carolina M Voloch; Ronaldo da Silva Francisco; Luiz G P de Almeida; Otavio J Brustolini; Cynthia C Cardoso; Alexandra L Gerber; Ana Paula de C Guimarães; Isabela de Carvalho Leitão; Diana Mariani; Victor Akira Ota; Cristiano X Lima; Mauro M Teixeira; Ana Carolina F Dias; Rafael Mello Galliez; Débora Souza Faffe; Luís Cristóvão Pôrto; Renato S Aguiar; Terezinha M P P Castiñeira; Orlando C Ferreira; Amilcar Tanuri; Ana Tereza R de Vasconcelos Journal: Virus Evol Date: 2021-09-29
Authors: Anastasia Meshcheryakova; Peter Pietschmann; Philip Zimmermann; Igor B Rogozin; Diana Mechtcheriakova Journal: Front Immunol Date: 2021-07-01 Impact factor: 7.561